Figure 3
The Initial (left) and final (right) snapshots of simulated boxes for nanosuspension at (a) bezafibrate and PVA, (b) flurbiprofen and PVA, (c) miconazol and PVA, and d) phenytoin and PVA.
Figure 3 | Scientific Reports
The Initial (left) and final (right) snapshots of simulated boxes for nanosuspension at (a) bezafibrate and PVA, (b) flurbiprofen and PVA, (c) miconazol and PVA, and d) phenytoin and PVA.
